Artur‐Aron Weber

3.2k total citations · 1 hit paper
61 papers, 2.4k citations indexed

About

Artur‐Aron Weber is a scholar working on Cardiology and Cardiovascular Medicine, Hematology and Pharmacology. According to data from OpenAlex, Artur‐Aron Weber has authored 61 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Cardiology and Cardiovascular Medicine, 27 papers in Hematology and 19 papers in Pharmacology. Recurrent topics in Artur‐Aron Weber's work include Antiplatelet Therapy and Cardiovascular Diseases (23 papers), Platelet Disorders and Treatments (18 papers) and Inflammatory mediators and NSAID effects (16 papers). Artur‐Aron Weber is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (23 papers), Platelet Disorders and Treatments (18 papers) and Inflammatory mediators and NSAID effects (16 papers). Artur‐Aron Weber collaborates with scholars based in Germany, Austria and United States. Artur‐Aron Weber's co-authors include Karsten Schrör, Mario Sarbia, Katja Zimmermann, F Borchard, Helmut E. Gabbert, Thomas Hohlfeld, Marina Braun, Karsten Schrör, Bernhard H. Rauch and Alexander Hermann and has published in prestigious journals such as The EMBO Journal, Blood and Circulation Research.

In The Last Decade

Artur‐Aron Weber

61 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cyclooxygenase-2 expression in human esophageal carcinoma.

1999 585 citations Artur‐Aron Weber, Karsten Schrör et al. profile →

Peers

Countries citing papers authored by Artur‐Aron Weber

Since Specialization

Citations

This map shows the geographic impact of Artur‐Aron Weber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Artur‐Aron Weber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Artur‐Aron Weber more than expected).

Fields of papers citing papers by Artur‐Aron Weber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Artur‐Aron Weber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Artur‐Aron Weber. The network helps show where Artur‐Aron Weber may publish in the future.

Co-authorship network of co-authors of Artur‐Aron Weber

This figure shows the co-authorship network connecting the top 25 collaborators of Artur‐Aron Weber. A scholar is included among the top collaborators of Artur‐Aron Weber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Artur‐Aron Weber. Artur‐Aron Weber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Adolescent ischemic stroke associated with anabolic steroid and cannabis abuse 2012 ·Journal of Pediatric Endocrinology and Metabolism ·(unknown), Artur‐Aron Weber, Dirk Klee, (unknown), Ertan Mayatepek, Michael Karenfort	11
2	8-pCPT-conjugated cyclic AMP analogs exert thromboxane receptor antagonistic properties 2010 ·Thrombosis and Haemostasis ·Maria Grandoch, (unknown), (unknown), (unknown), (unknown), Artur‐Aron Weber, Jens W. Fischer, K. Jakobs, Carsten Sand, Martina Schmidt	14
3	Thrombin receptors in vascular smooth muscle cells – function and regulation by vasodilatory prostaglandins 2010 ·Thrombosis and Haemostasis ·Ellen Bretschneider, Kerstin Fischer, Jens W. Fischer, R. De Pape, Bernhard H. Rauch, A Rosenkranz, Artur‐Aron Weber, Karsten Schrör	31
4	B cell receptor-induced growth arrest and apoptosis in WEHI-231 immature B lymphoma cells involve cyclic AMP and Epac proteins 2009 ·Cellular Signalling ·Maria Grandoch, Maider López de Jesús, Paschal A. Oude Weernink, Artur‐Aron Weber, Karl H. Jakobs, Martina Schmidt	25
5	Methods to Evaluate the Pharmacology of Oral Antiplatelet Drugs 2008 ·Herz ·Artur‐Aron Weber, Michael Adamzik, Hagen S. Bachmann, Klaus Görlinger, Maria Grandoch, Kirsten Leineweber, (unknown), Folker Wenzel, Christoph Naber	15
6	Δ6‐Desaturase (FADS2) deficiency unveils the role of ω3‐ and ω6‐polyunsaturated fatty acids 2008 ·The EMBO Journal ·Wilhelm Stoffel, Barbara Holz, Britta Jenke, Erika Binczek, Robert Heinz Günter, (unknown), Iakowos Karakesisoglou, Mario Thevis, Artur‐Aron Weber, (unknown), Klaus Addicks	187
7	Aspirin “Resistance” 2008 ·Herz ·Norbert Zimmermann, Artur‐Aron Weber, Thomas Hohlfeld	9
8	Messung der Thrombozytenfunktion mit Point-of-Care-Methoden 2008 ·Herz ·Klaus Görlinger, Csilla Jámbor, Daniel Dirkmann, Fabian Dusse, Alexander Hanke, Michael Adamzik, Matthias Hartmann, Sebastian Philipp, Artur‐Aron Weber, Niels Rahe‐Meyer	31
9	Platelet aggregation induced by the C-terminal peptide of thrombospondin-1 (4N1-1) is inhibited by epigallocatechin gallate but not by prostaglandin E₁ 2004 ·Platelets ·Thomas J. Neuhaus, (unknown), (unknown), H. Vetter, Karsten Schrör, Artur‐Aron Weber	8
10	Complex effects of different green tea catechins on human platelets 2003 ·FEBS Letters ·(unknown), (unknown), Karsten Schrör, Artur‐Aron Weber	53
11	The C‐terminal peptide of thrombospondin‐1 stimulates distinct signaling pathways but induces an activation‐independent agglutination of platelets and other cells 2003 ·FEBS Letters ·(unknown), Michael Udelhoven, (unknown), Barsom Aktas, Bernhard Nieswandt, Karsten Schrör, Artur‐Aron Weber	15
12	Comparative Pharmacology of GP IIb/IIIa Antagonists 2003 ·Journal of Thrombosis and Thrombolysis ·Karsten Schrör, Artur‐Aron Weber	81
13	CD40 ligand (CD40L) does not stimulate proliferation of vascular smooth muscle cells 2002 ·European Journal of Cell Biology ·Alexander Hermann, Karsten Schrör, Artur‐Aron Weber	11
14	Recovery of platelet function after discontinuation of clopidogrel treatment in healthy volunteers 2001 ·British Journal of Clinical Pharmacology ·Artur‐Aron Weber, Marina Braun, Thomas Hohlfeld, B. Schwippert, Diethelm Tschöpe, Karsten Schrör	132
15	Troglitazone and rosiglitazone induce apoptosis of vascular smooth muscle cells through an extracellular signal-regulated kinase-independent pathway 2001 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Claudia Seul, H. Vetter, Agapios Sachinidis, Ioanna Gouni‐Berthold, Heiner K. Berthold, Artur‐Aron Weber, Yon Ko	31
16	Complex actions of protein kinase A inhibitors on mitogenesis of bovine coronary artery smooth muscle cells 2000 ·European Journal of Pharmacology ·(unknown), Artur‐Aron Weber, Karsten Schrör	1
17	Tolerance development to antimitogenic actions of prostacyclin but not of prostaglandin E1 in coronary artery smooth muscle cells 1998 ·European Journal of Pharmacology ·Tom-Philipp Zucker, (unknown), (unknown), Tilo Großer, Artur‐Aron Weber, (unknown)	50
18	Antimitogenic Effects of Trapidil In Coronary Artery Smooth Muscle Cells by Direct Activation of Protein Kinase A 1998 ·Molecular Pharmacology ·(unknown), Artur‐Aron Weber, (unknown), (unknown), Karsten Schrör	30
19	Thromboxane A2 Potentiates Thrombin-Induced Proliferation of Coronary Artery Smooth Muscle Cells 1997 ·Advances in experimental medicine and biology ·Tom-Philipp Zucker, (unknown), (unknown), Artur‐Aron Weber, Ellen Bretschneider, Erika Glusa, Karsten Schrör	9
20	Biotransformation of glyceryl trinitrate by blood platelets as compared to vascular smooth muscle cells 1996 ·European Journal of Pharmacology ·Artur‐Aron Weber, Thomas J. Neuhaus, Claudia Seul, Rainer Düsing, Karsten Schrör, Agapios Sachinidis, H. Vetter	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact